Clinical Trial Update: Stress Reduction & CVD Morbidity and Mortality in Blacks [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether a stress reduction program reduces cardiovascular morbidity and mortality in Black participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Disease
• Hypertension
• Vascular Diseases

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 2 | Status: COMPLETED